126 related articles for article (PubMed ID: 31091594)
41. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
42. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
[TBL] [Abstract][Full Text] [Related]
43. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
[TBL] [Abstract][Full Text] [Related]
44. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
[TBL] [Abstract][Full Text] [Related]
45. Neuronal immunoexpression and a distinct subtype of adult primary supratentorial glioblastoma with a better prognosis.
Pallud J; Dezamis E; Audureau E; Devaux B; Souillard-Scemama R; Sanai N; Page P; Beuvon F; Koziak M; Oppenheim C; Dhermain F; Schlienger M; Meder JF; Roux FX; Varlet P
J Neurosurg; 2012 Sep; 117(3):476-85. PubMed ID: 22725988
[TBL] [Abstract][Full Text] [Related]
46. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
47. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
[TBL] [Abstract][Full Text] [Related]
48. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
49. Radical surgery and reoperation in supratentorial malignant glial tumors.
Daneyemez M; Gezen F; Canakçi Z; Kahraman S
Minim Invasive Neurosurg; 1998 Dec; 41(4):209-13. PubMed ID: 9932265
[TBL] [Abstract][Full Text] [Related]
50. Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.
Zhong J; Ali AN; Voloschin AD; Liu Y; Curran WJ; Crocker IR; Shu HK
Cancer; 2015 May; 121(9):1456-62. PubMed ID: 25557543
[TBL] [Abstract][Full Text] [Related]
51. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
52. Cerebellar glioblastoma multiforme: a retrospective study of 28 patients at a single institution.
Yang S; Liu J; Wang T; Li X; You C
Int J Neurosci; 2013 Oct; 123(10):691-7. PubMed ID: 23550813
[TBL] [Abstract][Full Text] [Related]
53. 1.5-T Field Intraoperative Magnetic Resonance Imaging Improves Extent of Resection and Survival in Glioblastoma Removal.
Marongiu A; D'Andrea G; Raco A
World Neurosurg; 2017 Feb; 98():578-586. PubMed ID: 27838425
[TBL] [Abstract][Full Text] [Related]
54. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ
Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726
[TBL] [Abstract][Full Text] [Related]
55. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era.
Ortega A; Sarmiento JM; Ly D; Nuño M; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2016 Feb; 24():105-11. PubMed ID: 26671314
[TBL] [Abstract][Full Text] [Related]
56. A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma.
Straube C; Kessel KA; Antoni S; Gempt J; Meyer B; Schlegel J; Schmidt-Graf F; Combs SE
Radiat Oncol; 2020 May; 15(1):97. PubMed ID: 32375830
[TBL] [Abstract][Full Text] [Related]
57. Supratentorial glioblastoma: neuroradiological findings and survival after surgery and radiotherapy.
Pierallini A; Bonamini M; Osti MF; Pantano P; Palmeggiani F; Santoro A; Maurizi Enrici R; Bozzao L
Neuroradiology; 1996 May; 38 Suppl 1():S26-30. PubMed ID: 8811675
[TBL] [Abstract][Full Text] [Related]
58. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
[TBL] [Abstract][Full Text] [Related]
59. Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.
Molitoris JK; Rao YJ; Patel RA; Kane LT; Badiyan SN; Gittleman H; Barnholtz-Sloan JS; Bentzen SM; Kruser TJ; Huang J; Mehta MP
J Neurooncol; 2017 Sep; 134(2):331-338. PubMed ID: 28643151
[TBL] [Abstract][Full Text] [Related]
60. The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.
Millward CP; Brodbelt AR; Haylock B; Zakaria R; Baborie A; Crooks D; Husband D; Shenoy A; Wong H; Jenkinson MD
Acta Neurochir (Wien); 2016 Oct; 158(10):1943-53. PubMed ID: 27526690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]